News Snapshot:
Dec. 30 (UPI) -- Chinese drugmaker Sinopharm said Wednesday that interim clinical trial results have shown that one of two COVID-19 vaccines it's testing is almost 80% effective in blocking the coronavirus. The results were announced and released by the Beijing Institute of Biological Products, a subsidiary of state-owned Sinopharm. Advertisement Company officials did not provide additional data, but said the vaccine has proven safe and that they will seek regulatory approvals for inoculations in China. The efficiency figure of 79% is well below those of vaccines developed by Pfizer-BioNTech and Moderna, which proved 95% efficient in clinical trials. The...
